Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model

AIDS Research and Human Retroviruses

Volumn 25, Issue 9, 2009, Pages 905-917

  Kersh, Ellen N ^a,b   Luo, Wei ^a   Adams, Debra R ^a   Srinivasan, Priya ^a   Smith, James M ^a   Promadej Lanier, Nattawan ^a   Ellenberger, Dennis ^a   Garcia Lerma, J Gerardo ^a   Butera, Salvatore ^a   Otten, Ron ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Mailstop A25 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; KI 67 ANTIGEN; RANTES; CYTOKINE; GRANZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE MODEL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; RECTUM; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIROLOGY;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; GRANZYMES; HIV; HIV INFECTIONS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MALE; RECTUM; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES;

EID: 70349272991     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0287     Document Type: Article

References (36)

1. Otten RA, Adams DR, Kim CN, et al.: Multiple vaginal exposures to low doses of R5 simian-human immunodefi-ciency virus: Strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 2005;191:164-173.
2. Regoes RR, Longini IM, Feinberg MB, and Staprans SI: Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Med 2005;2:e249.
3. Ma ZM, Abel K, Rourke T, Wang Y, and Miller CJ: A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 2004;78:14048-14052.
4. Ellenberger D, Otten RA, Li B, et al.: HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology 2006; 352:216-225.
5. Garcia-Lerma JG, Otten RA, Qari SH, et al.: Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 2008;5:e28.
6. Cohen MS: Preventing sexual transmission of HIV. Clin Infect Dis 2007;45(Suppl 4):S287-292.
7. Shearer GM and Clerici M: Protective immunity against HIV infection: Has nature done the experiment for us? Immunol Today 1996;17:21-24.
8. Rowland-Jones SL and McMichael A: Immune responses in HIV-exposed seronegatives: Have they repelled the virus? Curr Opin Immunol 1995;7:448-455.
9. Kulkarni PS, Butera ST, and Duerr AC: Resistance to HIV-1 infection: Lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals. AIDS Rev 2003;5:87-103.
10. Rowland-Jones SL, Dong T, Fowke KR, et al.: Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758-1765.
11. Alimonti JB, Kimani J, Matu L, et al.: Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol 2006;84:482-485.
12. Kaul R, Dong T, Plummer FA, et al.: CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001;107:1303-1310.
13. Kaul R, Rowland-Jones SL, Kimani J, et al.: New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001;79:3-13. (Pubitemid 32938202)
14. Lo Caputo S, Trabattoni D, Vichi F, et al.: Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 2003;17:531-539.
15. Schenal M, Lo Caputo S, Fasano F, et al.: Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 2005;19:653-661.
16. Letvin NL and Walker BD: HIV versus the immune system: Another apparent victory for the virus. J Clin Invest 2001; 107:273-275.
17. Hladik F, Desbien A, Lang J, et al.: Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol 2003;171:2671-2683.
18. Zhu T, Corey L, Hwangbo Y, et al.: Persistence of extraordinarily low levels of genetically homogeneous human im-munodeficiency virus type 1 in exposed seronegative individuals. J Virol 2003;77:6108-6116.
19. Beattie T, Rowland-Jones S, and Kaul R: HIV-1 and AIDS: What are protective immune responses? J HIV Ther 2002; 7:35-39.
20. Subbarao S, Otten RA, Ramos A, et al.: Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis 2006;194:904-911.
21. Harouse JM, Gettie A, Eshetu T, et al.: Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 2001;75:1990-1995.
22. Harouse JM, Gettie A, Tan RC, Blanchard J, and Cheng-Mayer C: Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284:816-819.
23. Pahar B, Wang X, Dufour J, Lackner AA, and Veazey RS: Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3). Virology 2007;363:36-47.
24. Kersh EN, Luo W, Adams DR, et al.: No evidence of occult SHIV infection as demonstrated by CD8(+) cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS Res Hum Retroviruses 2008;24:543-546.
25. Smith JG, Joseph HR, Green T, et al.: Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin Vaccine Immunol 2007;14:527-537.
26. Promadej-Lanier N, Srinivasan P, Curtis K, et al.: Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques. Virology 2008; 375:492-503.
27. Cossarizza A, Ortolani C, Mussini C, et al.: Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis 1995;172:105-112.
28. Tasca S, Tsai L, Trunova N, et al.: Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure. Virology 2007;367:196-211.
29. Miller CJ, Marthas M, Torten J, et al.: Intravaginal inoculation of rhesus macaques with cell-free simian immunodefi-ciency virus results in persistent or transient viremia. J Virol 1994;68:6391-6400.
30. Trivedi P, Horejsh D, Hinds SB, et al.: Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J Virol 1996;70:6876-6883.
31. Van Rompay KK, Marthas ML, Lifson JD, et al.: Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses 1998;14:761-773.
32. McChesney MB, Collins JR, Lu D, et al.: Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998;72:10029-10035.
33. Murphey-Corb M, Wilson LA, Trichel AM, et al.: Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 1999;162:540-549.
34. Petry H, Dittmer U, Stahl-Hennig C, Jurkiewicz E, Hunsmann G, and Luke W: Silent infection of macaques inoculated with low-dose SIVmac251/spl. AIDS Res Hum Retroviruses 1997;13:1355-1356.
35. Letvin NL, Rao SS, Dang V, et al.: No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 2007;81:12368-12374.
36. Douek DC, Brenchley JM, Betts MR, et al.: HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417:95-98.